Home Newsfeeds Raymond James Maintains Outperform on bluebird bio, Raises Price Target to $10

Raymond James Maintains Outperform on bluebird bio, Raises Price Target to $10

Raymond James analyst Dane Leone maintains bluebird bio (NASDAQ:BLUE) with a Outperform and raises the price target from $8 to $10.

byBenzinga Newsdesk

September 20, 2022

1 minute read

Raymond James analyst Dane Leone maintains bluebird bio (NASDAQ:BLUE) with a Outperform and raises the price target from $8 to $10.

Accenture Federal Services Wins TSA Flexible Agile Scalable Teams Blanket Purchase Agreement With $170M Ceiling Value

By Benzinga Newsdesk

June 10, 9:08 AM

Company to Deliver Flexible Agile Scalable Teams (FAST) Support ServicesAccenture Federal Services has been awarded a Transportation Security Administration (TSA) Security Operations (SO) Flexible Agile Scalable Teams

ACN

Reported Earlier, Putin Announces Russia To Pull Out Of New Start Nuclear Treaty With U.S.

By Happy Mohamed

February 21, 9:30 AM

https://www.theguardian.com/world/live/2023/feb/21/russia-ukraine-war-biden-arrives-in-poland-putin-to-make-state-of-the-nation-address-live#maincontent That was a long speech by Russian president Vladimir Putin,

SPY

Barclays Maintains Equal-Weight on Zscaler, Raises Price Target to $175

By Benzinga Newsdesk

September 9, 7:05 AM

Barclays analyst Saket Kalia maintains Zscaler (NASDAQ:ZS) with a Equal-Weight and raises the price target from $168 to $175.

M&A
News

Hanger Stockholders Approve Acquisition by Patient Square Capital

By Michael Horton

September 30, 4:10 PM

Hanger, Inc. (NYSE:HNGR), a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, today announced that its stockholders approved at a special meeting the acquisition of Hanger by

HNGR

Raymond James Maintains Outperform on bluebird bio, Raises Price Target to $10

Related Posts

Accenture Federal Services Wins TSA Flexible Agile Scalable Teams Blanket Purchase Agreement With $170M Ceiling Value

Reported Earlier, Putin Announces Russia To Pull Out Of New Start Nuclear Treaty With U.S.

Barclays Maintains Equal-Weight on Zscaler, Raises Price Target to $175

Hanger Stockholders Approve Acquisition by Patient Square Capital